http://dermatologytimes.modernmedicine.com/dermatologytimes The Leading Newsmagazine for Dermatologists. Dermatology Times is a newsmagazine devoted to reporting timely information on the latest trends in the dermatology market. As such, it covers new procedures; advances in therapy, new products and drugs, the latest information presented at meetings, interviews with leaders in practice, academics and research. 2008-08-21T17:21:52Z http://dermatologytimes.modernmedicine.com/dermatologytimes/Web+Exclusive/Teaming-up-Vascular-anomaly-centers-focus-on-multi/ArticleStandard/Article/detail/543468?ref=25 Chicago — The concept of too many cooks in the kitchen does not apply to treating vascular anomalies. In fact, experts say, even dermatologists often need to tap into the expertise of multidisciplinary centers that focus on vascular anomalies and other "orphan" skin diseases in order to offer optimum care — especially for their pediatric patients. 2008-08-20T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/342008/543468/child_in_hospital_thumbnail.jpg http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/342008/543468null HTML http://dermatologytimes.modernmedicine.com/dermatologytimes/Research+Briefs/Study-lets-teens-talk-about-acne-therapies/ArticleStandard/Article/detail/543037?ref=25 San Francisco — American teens would pay an average of $275 to have never had acne, according to a study, published in the Archives of Dermatology, where researchers surveyed 266 high school students in San Francisco. 2008-08-19T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/342008/543037null HTML http://dermatologytimes.modernmedicine.com/dermatologytimes/Industry+News/FDA-clears-Iridex-IQ-Laser-Systems/ArticleStandard/Article/detail/542796?ref=25 Mountain view, Calif. — Iridex Corporation says it has received clearance from the U.S. Food and Drug Administration (FDA) for its IQ Laser Systems, according to BioOptics World. 2008-08-18T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/342008/542796null HTML http://dermatologytimes.modernmedicine.com/dermatologytimes/Research+Briefs/Study-Moisturizers-raise-skin-cancer-risk/ArticleStandard/Article/detail/542288?ref=25 New Brunswick, N.J. — Common moisturizers increase the production of tumors in mice that have previously been exposed to UV rays, according to a study published in the Journal of Investigative Dermatology. 2008-08-14T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/332008/542288null HTML http://dermatologytimes.modernmedicine.com/dermatologytimes/Industry+News/Obagi-Medical-launches-SoluCLENZ-Rx-Gel-for-the-tr/ArticleStandard/Article/detail/542017?ref=25 Long beach, Calif. — Obagi Medical Products announces the launch of SoluCLENZ Rx Gel,a solubilized benzoyl peroxide, used for the treatment of acne, according to marketwatch. 2008-08-13T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/332008/542017null HTML http://dermatologytimes.modernmedicine.com/dermatologytimes/Research+Briefs/Black-henna-can-cause-serious-skin-reactions/ArticleStandard/Article/detail/535124?ref=25 Chicago — Dermatologists warn consumers that black henna tattoos contain para-phenylenediamine (PPD), a harmful chemical associated with a rash and major skin problems, according to PR Newswire. 2008-08-11T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/332008/535124null HTML http://dermatologytimes.modernmedicine.com/dermatologytimes/Industry+News/Cipher-announces-US-distribution-and-supply-agreem/ArticleStandard/Article/detail/534791?ref=25 Mississauga, Ontario — Cipher Pharmaceuticals announces it has entered into a distribution and supply agreement with Ranbaxy Laboratories Limited for Ranbaxy to market, sell and distribute CIP-ISOTRETINOIN in the United States, MarketWatch reports. 2008-08-08T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/322008/534791null HTML http://dermatologytimes.modernmedicine.com/dermatologytimes/Research+Briefs/Anti-parasite-drug-targets-cancer-causing-protein/ArticleStandard/Article/detail/534557?ref=25 New York — Researchers have found mebendazole, a widely prescribed drug used to treat parasitic infections, to be a a viable investigational agent for the treatment of chemotherapy-resistant malignant melanoma, ScienceDaily reports. 2008-08-07T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/322008/534557null HTML http://dermatologytimes.modernmedicine.com/dermatologytimes/Industry+News/New-dermal-filler-launched/ArticleStandard/Article/detail/534225?ref=25 San Diego — Artes Medical announces the immediate launch and commercial sale of Food and Drug Administration-approved Elevess, a new hyaluronic acid dermal filler formulated with an anesthetic for patient comfort, according to a press release. 2008-08-06T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/322008/534225null HTML http://dermatologytimes.modernmedicine.com/dermatologytimes/California-legislators-defeat-bill-requiring-proof/ArticleStandard/Article/detail/533146?ref=25 Sacramento, Calif. — The California Assembly’s Committee on Health has defeated a bill that would have required manufacturers — including lipstick-makers — to prove that their products contain no more than “an unavoidable trace of lead,” CosmeticsDesign.com reports. 2008-08-05T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/312008/533146null HTML http://dermatologytimes.modernmedicine.com/dermatologytimes/Accrediting-agency-cracks-down-on-physiciansrsquo-/ArticleStandard/Article/detail/533139?ref=25 Chicago — A national hospital-accrediting agency has issued new requirements aimed at minimizing the kind of physician behavior that can lead to medical errors, the Associated Press reports. 2008-08-05T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/312008/533139null HTML http://dermatologytimes.modernmedicine.com/dermatologytimes/Tufts-report-reveals-increasing-use-of-post-releas/ArticleStandard/Article/detail/533142?ref=25 Boston — A recently released analysis shows that studies of prescription drugs following their release on the market are becoming more common in the United States, Europe and Japan, The Boston Globe reports. 2008-08-05T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/312008/533142null HTML http://dermatologytimes.modernmedicine.com/dermatologytimes/Opponents-square-off-in-online-debate-over-whether/ArticleStandard/Article/detail/533143?ref=25 London — The issue of whether sun exposure is a major cause of melanoma is the subject of two opposing articles published July 22 on bmj.com, the Web site of the British Medical Journal, HealthDay News reports. 2008-08-05T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/312008/533143null HTML http://dermatologytimes.modernmedicine.com/dermatologytimes/PhRMA-survey-offers-insights-on-doctorsrsquo-presc/ArticleStandard/Article/detail/533141?ref=25 Washington — More than 90 percent of physicians base their drug-prescribing decisions on multiple sources of information, according to a new survey conducted by the Pharmaceutical Research and Manufacturers of America (PhRMA), PRNewswire reports. 2008-08-05T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/312008/533141null HTML http://dermatologytimes.modernmedicine.com/dermatologytimes/Study-makes-case-for-renewed-interest-in-carbon-di/ArticleStandard/Article/detail/533144?ref=25 Ann Arbor, Mich. — New research suggests that a form of laser cosmetic surgery first used two decades ago — but which has since fallen out of favor — could make a comeback in treating facial wrinkles, London’s Daily Mail reports. 2008-08-05T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/312008/533144null HTML http://dermatologytimes.modernmedicine.com/dermatologytimes/Allergan-completes-purchase-of-acne-treatment-drug/ArticleStandard/Article/detail/533140?ref=25 Irvine, Calif. — Allergan, based here, has finalized a deal to acquire acne treatment gel Aczone from QLT USA Inc., the Associated Press reports. 2008-08-05T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/312008/533140null HTML http://dermatologytimes.modernmedicine.com/dermatologytimes/Results-of-Pegintron-study-show-reduced-rate-of-po/ArticleStandard/Article/detail/533145?ref=25 Rotterdam, Netherlands — Researchers here say that Pegintron, a hepatitis C drug marketed by Schering-Plough Corp., helps stop the post-surgery return of melanoma, Reuters reports. 2008-08-05T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/312008/533145null HTML http://dermatologytimes.modernmedicine.com/dermatologytimes/August-E-news-art/ArticleStandard/Article/detail/533478?ref=25 2008-08-04T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/322008/533478null HTML http://dermatologytimes.modernmedicine.com/dermatologytimes/Dermatology/Molecular-biology-Researchers-introduce-new-advanc/ArticleStandard/Article/detail/535081?ref=25 Researchers' growing understanding of melanoma's molecular biology is facilitating the development of more effective treatments that may be combined with some existing agents, an expert says. 2008-08-01T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/332008/535081null XML http://dermatologytimes.modernmedicine.com/dermatologytimes/Special+Report%3A+Athletes+%26+Skin+Disease/Athletic-skin-afflictions-Sports-cause-inflammatio/ArticleStandard/Article/detail/535074?ref=25 A wide variety of athletic pursuits can result in various skin problems, ranging from fungal conditions to inflammatory issues. Some can easily be mistaken for other skin conditions, and physicians should make themselves aware of what to look for. 2008-08-01T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/332008/535074null XML http://dermatologytimes.modernmedicine.com/dermatologytimes/Dermatology/Long-term-care-Green-process-is-ongoing-for-Va-med/ArticleStandard/Article/detail/535055?ref=25 At Nova Medical, the largest primary care practice in Loudoun County, Va., "The process of going green is ongoing," says Jennifer Stokols, M.S., a registered dietitian who heads Nova Medical's green team. 2008-08-01T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/332008/535055null XML http://dermatologytimes.modernmedicine.com/dermatologytimes/Dermatology/Opinion-Another-year-another-paycut-Medicare-reimb/ArticleStandard/Article/detail/535059?ref=25 Another Medicare paycut — this one, an average 5.4 percent — is looming for 2009, as well as rule changes affecting the ability of dermatologists to provide diagnostic tests for patients without running afoul of federal physician self-referral and anti-markup prohibitions. 2008-08-01T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/332008/535059null XML http://dermatologytimes.modernmedicine.com/dermatologytimes/Dermatology/Opinion-Influencing-healthcare-reform/ArticleStandard/Article/detail/535060?ref=25 Both sides of the aisle are talking about making healthcare a campaign issue in the upcoming national elections. 2008-08-01T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/332008/535060null XML http://dermatologytimes.modernmedicine.com/dermatologytimes/Special+Report%3A+Athletes+%26+Skin+Disease/The-fungus-among-us-Controlling-athletes-foot-jock/ArticleStandard/Article/detail/535071?ref=25 There is no way to avoid getting athlete's foot, which can be transmitted to produce "jock itch" in men. The key to treatment is to give medication enough time to work, and to knock out the fungus in the feet and toes so it doesn't recur in the groin area. 2008-08-01T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/332008/535071/Slide3_flash.jpg XML http://dermatologytimes.modernmedicine.com/dermatologytimes/Pediatric+Dermatology/Understanding-hemangiomas-of-infancy-Problematic-h/ArticleStandard/Article/detail/535066?ref=25 Recognizing pediatric hemangiomas that require close follow-up and aggressive treatment is critical to patient care, an expert says. 2008-08-01T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/332008/535066null XML http://dermatologytimes.modernmedicine.com/dermatologytimes/Cosmetic+Dermatology/CO2-laser-blepharoplasty-Fractional-periocular-res/ArticleStandard/Article/detail/535176?ref=25 Used in combination, CO2 laser blepharoplasty and fractional periocular resurfacing offer a safe, effective approach to rejuvenating the eye area, an oculoplastic surgeon says. 2008-08-01T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/332008/535176null XML http://dermatologytimes.modernmedicine.com/dermatologytimes/Special+Report%3A+Athletes+%26+Skin+Disease/Athletes-and-acne-mechanica-Look-to-nonporous-mate/ArticleStandard/Article/detail/535072?ref=25 Physicians who work with teens, athletes or even musicians are likely to encounter acne mechanica. Characterized by small red bumps, acne mechanica typically occurs when nonporous material, such as a strap or helmet, is in regular contact with the skin. 2008-08-01T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/332008/535072null XML http://dermatologytimes.modernmedicine.com/dermatologytimes/Cosmetic+Dermatology/Botox-tips-Conservative-technique-allows-natural-c/ArticleStandard/Article/detail/535076?ref=25 Tips for botulinum toxin injections include using the smallest effective dose, clearly marking injection sites before treatment , and considering male versus female aesthetic standards, an expert says. 2008-08-01T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/332008/535076null XML http://dermatologytimes.modernmedicine.com/dermatologytimes/Finance/Column-Weighing-the-options-Protecting-your-assets/ArticleStandard/Article/detail/535082?ref=25 You don't need to read another article telling you how terrible the malpractice crisis is. You already know that lawsuits are on the rise, jury awards are out of control, malpractice premiums are escalating to the point of being unaffordable, and the practice of medicine as we know it is severely threatened. 2008-08-01T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/332008/535082null XML http://dermatologytimes.modernmedicine.com/dermatologytimes/Dermatology/HPV-strategy-Lessons-from-basic-science-research-p/ArticleStandard/Article/detail/535068?ref=25 Ian H. Frazer, M.D., in collaboration with Jian Zhou, Ph.D., developed the virus-like particle technology that led to the design of effective vaccines for preventing infection with HPV types causing anogenital warts and certain cancers, particularly cervical cancer. 2008-08-01T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/332008/535068null XML http://dermatologytimes.modernmedicine.com/dermatologytimes/Dermatology/Alternative-treatments-Herbs-enzymes-antioxidants-/ArticleStandard/Article/detail/535057?ref=25 The following list details common skin conditions and suggested natural treatments, based on information provided by Helen M. Torok, M.D. 2008-08-01T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/332008/535057null XML http://dermatologytimes.modernmedicine.com/dermatologytimes/Special+Report%3A+Athletes+%26+Skin+Disease/Using-teamwork-Athletes-at-risk-for-developing-MRS/ArticleStandard/Article/detail/535069?ref=25 Athletes who participate in team sports are at an elevated risk of developing certain skin conditions, such as methicillin-resistant Staphylococcus aureus. Team physicians should be checking for contagions, such as fungi on the body, and ensure athletes shower after practice and wear clean, dry clothing. 2008-08-01T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/332008/535069/athletes-in-lockerroom_flash.jpg XML http://dermatologytimes.modernmedicine.com/dermatologytimes/Acne/Taking-the-red-out-of-rosacea-Topical-alpha-1-adre/ArticleStandard/Article/detail/535065?ref=25 Topical treatment with a 0.05 percent solution of oxymetazoline in a small series of patients with erythematotelangiectatic rosacea has been associated with encouraging efficacy for reducing erythema and preventing erythematous flares. Aspect Pharmaceuticals is planning a clinical trial of a formula optimized for dermatologic use. 2008-08-01T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/332008/535065null XML http://dermatologytimes.modernmedicine.com/dermatologytimes/Dermatology/Getting-cheeky-Midface-area-is-key-to-overall-pati/ArticleStandard/Article/detail/535164?ref=25 In rejuvenating the midface, it's important to remember the impact that addressing lost cheek volume has both in this area and on the lower face, a Canadian expert says. 2008-08-01T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/332008/535164null XML http://dermatologytimes.modernmedicine.com/dermatologytimes/Dermatology/Going-green-Patients-demand-more-than-token-enviro/ArticleStandard/Article/detail/535053?ref=25 As consumers' environmental awareness grows, dermatologists must at least keep pace, experts say. Put more bluntly, adopting environmentally responsible practices can help dermatologists protect both the planet and their bottom lines, they explain. 2008-08-01T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/332008/535053null XML http://dermatologytimes.modernmedicine.com/dermatologytimes/Dermatology/Miscalculating-morbidity-Deaths-from-cutaneous-T-c/ArticleStandard/Article/detail/535080?ref=25 Cutaneous T-cell lymphoma rates may be on the rise, but a recent study shows that there are gross misclassifications occurring in respect to the mortality rates of this disease. 2008-08-01T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/332008/535080null XML http://dermatologytimes.modernmedicine.com/dermatologytimes/Special+Report%3A+Athletes+%26+Skin+Disease/Bacterial-skin-infections-Sweating-abrasions-incre/ArticleStandard/Article/detail/535070?ref=25 Sweating increases athletes' risks for bacterial skin infections, from impetigo to pitted keratolysis. Sweating combined with contact sports increases those risks. 2008-08-01T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/332008/535070/8801_Pittea-Kerytolysis_rev_flash.jpg XML http://dermatologytimes.modernmedicine.com/dermatologytimes/Dermatology/Calling-a-halt-CD4-T-cell-therapy-can-control-adva/ArticleStandard/Article/detail/535062?ref=25 A proof-of-concept study has shown, for the first time, that it is possible to control and perhaps eradicate advanced melanoma using only a patient's cloned CD4 T cells. 2008-08-01T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/332008/535062null XML http://dermatologytimes.modernmedicine.com/dermatologytimes/Cosmetic+Dermatology/Natural-skincare-While-searching-for-products-derm/ArticleStandard/Article/detail/535056?ref=25 As consumers' demand for environmentally responsible medicines and medical practices has grown, so has their desire for "green" cosmetics, cosmeceuticals and skincare products. 2008-08-01T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/332008/535056null XML http://dermatologytimes.modernmedicine.com/dermatologytimes/Column/Q-amp-A-Coffee-anyone-Coffee-berry-extract-contain/ArticleStandard/Article/detail/535163?ref=25 Coffee berry extract is an antioxidant blend found as the signature ingredient in a new line of physician-dispensed cosmeceuticals, consisting of a cleanser, morning moisturizer and evening moisturizer. 2008-08-01T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/332008/535163null XML http://dermatologytimes.modernmedicine.com/dermatologytimes/Special+Report%3A+Athletes+%26+Skin+Disease/Avoiding-flare-ups-Athletes-must-take-proper-preca/ArticleStandard/Article/detail/535073?ref=25 Atopic dermatitis and photosensitivity can cause enough problems for victims of these conditions, but when the sufferers are also active in sports, the conditions can become even more aggravating, and there's not much that can be done other than treating and coping with the ailments. 2008-08-01T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/332008/535073null XML http://dermatologytimes.modernmedicine.com/dermatologytimes/Cosmetic+Dermatology/Bimatoprost-boom-Allergans-bid-for-eyelash-growth-/ArticleStandard/Article/detail/535054?ref=25 Allergan's proposed new product for stimulating natural growth in eyelashes may unleash a vibrant new cosmetic drug niche market. 2008-08-01T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/332008/535054null XML http://dermatologytimes.modernmedicine.com/dermatologytimes/Dermatology/Photodynamic-therapy-and-skin-cancer-Technique-eff/ArticleStandard/Article/detail/535078?ref=25 There is increasing evidence demonstrating that photodynamic therapy is effective in the treatment of actinic keratosis, Bowen's Disease (squamous cell carcinoma in situ), as well as superficial and nodular basal cell carcinoma. 2008-08-01T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/332008/535078null XML http://dermatologytimes.modernmedicine.com/dermatologytimes/Dermatology/Topical-troubles-Treatment-may-increase-lymphoma-r/ArticleStandard/Article/detail/535079?ref=25 Results of a recent study indicate that there is an increase in the incidence of lymphoma among atopic dermatitis patients using topical corticosteroids. 2008-08-01T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/332008/535079null XML http://dermatologytimes.modernmedicine.com/dermatologytimes/Physician%27s+Profile/Physicians-Profile-Trailblazing-derm-promotes-volu/ArticleStandard/Article/detail/535083?ref=25 Dermatologist Suzanne M. Connolly, M.D., thrives on the opportunity to join forces with others to make differences in people's lives. 2008-08-01T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/332008/535083/photo2_flash.jpg XML http://dermatologytimes.modernmedicine.com/dermatologytimes/Special+Report%3A+Athletes+%26+Skin+Disease/Elemental-worries-Exposure-to-sun-water-altitude-p/ArticleStandard/Article/detail/535075?ref=25 Environmental elements can increase risks for sun damage, particularly for athletes who spend extended periods outdoors. Athletes should protect themselves by wearing waterproof sunscreens with a very high sun protection factor number, such as SFP 50 and above. Wearing protective clothing is another precautionary measure that athletes can take. 2008-08-01T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/332008/535075null XML http://dermatologytimes.modernmedicine.com/dermatologytimes/Dermatology/Remote-viewing-Teledermatology-increases-access-to/ArticleStandard/Article/detail/535063?ref=25 With constraints on healthcare human resources in some geographic areas in Canada, teledermatology offers advantages, such as increasing access to dermatological expertise. The use of store-and-forward technology avoids the logistical challenges associated with real-time teledermatology. 2008-08-01T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/332008/535063null XML http://dermatologytimes.modernmedicine.com/dermatologytimes/Dermatology/Legal-My-pharm-rep-only-gave-me-a-pen/ArticleStandard/Article/detail/535061?ref=25 Dr. Gift has practiced dermatology for 15 years and has enjoyed a long-term relationship with many of his pharmaceutical representatives. For years, he has enjoyed lavish dinners and sporting events; his staff has enjoyed wonderful lunches and dinners. At all such events, both he and his staff learned something. 2008-08-01T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/332008/535061null XML http://dermatologytimes.modernmedicine.com/dermatologytimes/Lasers/Riding-the-wave-Newer-innovative-laser-technologie/ArticleStandard/Article/detail/535162?ref=25 According to one expert, continued research in laser surgery has given birth to new and innovative technologies for treating vascular lesions, such as newer wavelengths and combinations of wavelengths. 2008-08-01T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/332008/535162null XML http://dermatologytimes.modernmedicine.com/dermatologytimes/Finance/Column-Feeling-the-crunch-Unstable-market-affects-/ArticleStandard/Article/detail/535169?ref=25 The subprime mortgage crunch is rippling through our economy in a variety of different ways. Many homeowners are postponing plans to sell until the market stabilizes; others, with hopes for trading up to a bigger home, are opting to stay put, turning instead to remodeling or enlarging. 2008-08-01T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/332008/535169null XML http://dermatologytimes.modernmedicine.com/dermatologytimes/Dermatology/HIPAA-Deadlines-impact-Mohs-labs/ArticleStandard/Article/detail/535077?ref=25 For Mohs surgical practices, the Health Information Portability and Accountability Act (HIPAA) requires special attention to dry-erase boards used to track cases and to the possibility of patients overhearing discussions about slides and specimens, an expert says. 2008-08-01T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/332008/535077null XML http://dermatologytimes.modernmedicine.com/dermatologytimes/Dermatology/Pemphigus-vulgaris-Retrospective-analysis-supports/ArticleStandard/Article/detail/535067?ref=25 A retrospective analysis was conducted to examine relapse rates in patients treated with various regimens for moderate-to-severe pemphigus vulgaris. Cyclophosphamide as an adjuvant to prednisone demonstrated positive outcomes and an acceptable safety profile. 2008-08-01T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/332008/535067null XML http://dermatologytimes.modernmedicine.com/dermatologytimes/Dermatology/Front-line-dermatology-Jack-of-all-trades-doctor-d/ArticleStandard/Article/detail/535064?ref=25 Returning from Iraq, a military dermatologist discusses the challenges of being a "jack of all trades" on the front line. 2008-08-01T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/332008/535064null XML http://dermatologytimes.modernmedicine.com/dermatologytimes/Dermatology/Commentary-Treating-patients-in-the-information-ag/ArticleStandard/Article/detail/535058?ref=25 When I enrolled in medical school — what seems like a lifetime ago — I wanted to be akin to the sage and compassionate Marcus Welby, M.D. I wanted to be a pediatrician who takes care of and cures sick children. 2008-08-01T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/332008/535058null XML http://dermatologytimes.modernmedicine.com/dermatologytimes/Research+Briefs/Obagi-Medical-Products-presents-promising-iin-vitr/ArticleStandard/Article/detail/533007?ref=25 Chicago — Obagi Medical Products announces in vitro data showing that Obagi-C Rx Serum provided more than 10 times the absorption of vitamin C than the leading competitive product, Skinceuticals, according to Marketwatch.com. 2008-07-31T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/312008/533007null HTML http://dermatologytimes.modernmedicine.com/dermatologytimes/Industry+News/Alma-Lasers-announces-FDA-clearance-of-Pixel-CO2-O/ArticleStandard/Article/detail/532991?ref=25 Chicago — Alma Lasers announces Food and Drug Administration (FDA) clearance and availability of the Pixel CO2 OMNIFIT handpiece for skin resurfacing, Marketwatch.com reports. 2008-07-31T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/312008/532991null HTML http://dermatologytimes.modernmedicine.com/dermatologytimes/Research+Briefs/MacroChem-announces-phase-2-data-for-EcoNail-in-tr/ArticleStandard/Article/detail/531609?ref=25 New York — MacroChem Corporation announces results of a phase 2 clinical trial of EcoNail,a topical antifungal for the treatment of onychomychosis, according to Earthtimes.org. 2008-07-24T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/302008/531609null HTML http://dermatologytimes.modernmedicine.com/dermatologytimes/Modern+Medicine+News/NovaBay-anounces-details-of-dermatology-program/ArticleStandard/Article/detail/530891?ref=25 Emeryville, Calif. — NovaBay Parmaceuticals announces it has successfully developed several formulations of Agonocide compounds for use in dermatology. 2008-07-21T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/302008/530891null HTML http://dermatologytimes.modernmedicine.com/dermatologytimes/Web+Exclusive/Surviving-melanoma-California-woman-marks-five-yea/ArticleStandard/Article/detail/530400?ref=25 Napa, Calif. — Stage 4 melanoma survivor Kari Worth, 41, marked her five-year triumph over the disease with a five-day, 76-mile walk, ending with a trip across San Francisco’s Golden Gate Bridge to deliver a bottle of champagne to her oncologist. 2008-07-17T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/292008/530400/W7100.Worth.walker_thumbnail.jpg http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/292008/530400null HTML http://dermatologytimes.modernmedicine.com/dermatologytimes/Industry+News/Galderma-approved-for-DifferinR-Gel-01-percent-in-/ArticleStandard/Article/detail/530378?ref=25 Lausanne, Switzerland — Galderma Pharma S.A. announced that Japan’s Health Labor and Welfare has approved Differin(R) Gel 0.1 percent (adapalene). 2008-07-17T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/292008/530378null HTML http://dermatologytimes.modernmedicine.com/dermatologytimes/Industry+News/York-Pharma-raises-pound28-million-to-fund-acquisi/ArticleStandard/Article/detail/530080?ref=25 Milton Keynes, England — York Pharma has raised £28 million to fund a multi-million pound acquisition of Flammazine and Flammacerium from Solvay, according to BusinessWeekly.co.uk. 2008-07-16T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/292008/530080null HTML http://dermatologytimes.modernmedicine.com/dermatologytimes/Research+Briefs/Melanoma-rates-rise-in-younger-women/ArticleStandard/Article/detail/529372?ref=25 National report — The rate of melanoma cases in younger women has increased 50 percent since 1980, but did not increase in younger men, according to a study published in the Journal of Investigative Dermatology. 2008-07-14T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/292008/529372null HTML http://dermatologytimes.modernmedicine.com/dermatologytimes/Industry+News/Dermatology-Foundation-seeks-award-nominees/ArticleStandard/Article/detail/529268?ref=25 Evanston, Ill. —The Dermatology Foundation is accepting nominations for the 2008 Clark W. Finnerud and 2008 Practitioner of the Year awards. 2008-07-11T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/282008/529268null HTML http://dermatologytimes.modernmedicine.com/dermatologytimes/Research+Briefs/UV-light-therapy-as-beneficial-for-darker-skin-as-/ArticleStandard/Article/detail/528610?ref=25 Dallas — An analysis of more than 100 patients shows that darker-skinned patients benefit from light therapy to treat morphea and related diseases as much as lighter-skinned patients, according to ScienceDaily. 2008-07-09T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/282008/528610null HTML http://dermatologytimes.modernmedicine.com/dermatologytimes/Industry+News/FDA-approves-Evolence-for-treating-facial-wrinkles/ArticleStandard/Article/detail/528253?ref=25 National report — The U.S. Food and Drug Administration has approved Evolence to treat moderate-to-severe facial wrinkles and folds, according to maker Johnson and Johnson. 2008-07-08T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/282008/528253null HTML http://dermatologytimes.modernmedicine.com/dermatologytimes/Research+Briefs/Etanercept-demonstrates-therapeutic-effect-on-kelo/ArticleStandard/Article/detail/528302?ref=25 National report — A study shows that intralesional etanercept may provide an effective treatment for keloids, according to TherapeuticsDaily. 2008-07-08T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/282008/528302null HTML http://dermatologytimes.modernmedicine.com/dermatologytimes/Industry+News/Thermage-to-buy-Reliant-for-875-million-plus-debt/ArticleStandard/Article/detail/528346?ref=25 New York — Thermage, which makes an anti-aging skin tightening device, announced it will buy Reliant Technologies for $87.5 million in stock and cash, according to the Associated Press. 2008-07-08T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/282008/528346null HTML http://www.modernmedicine.com/modernmedicine/Industry+News/The-Skin-Cancer-Foundation-call-for-submissions-fo/ArticleStandard/Article/detail/527631?ref=25 National report — The Skin Cancer Foundation is accepting applications for support of pilot research projects related to skin cancer, according to a press release. 2008-07-02T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/272008/527631null HTML http://www.modernmedicine.com/modernmedicine/Research+Briefs/One-million-new-skin-cancer-cases-expected-in-US-t/ArticleStandard/Article/detail/527636?ref=25 Schaumburg, Ill. — Approximately one million new skin cancer cases will be diagnosed in the United States in 2008, according the the American Academy of Dermatology. 2008-07-02T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/272008/527636null HTML http://www.modernmedicine.com/modernmedicine/News/Brain-drain-Dermatologists-shunning-leaving-academ/ArticleStandard/Article/detail/528086?ref=25 While schools known for academic dermatology produce and retain a relatively high proportion of academic dermatologists, the career path on the whole suffers from low interest among recent graduates — and high attrition rates over time, experts say. 2008-07-01T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/282008/528086null XML http://www.modernmedicine.com/modernmedicine/News/Military-gains-Regenerative-medicine-project-will-/ArticleStandard/Article/detail/528087?ref=25 The Department of Defense (DOD) has awarded a multimillion-dollar research grant to develop new therapies for wounded soldiers, which may hasten the pace at which unique, innovative burn and wound healing and cosmetic procedures become commonly used in treating civilians. 2008-07-01T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/282008/528087null XML http://www.modernmedicine.com/modernmedicine/Other/After-the-burn-Encouraging-results-from-autologous/ArticleStandard/Article/detail/528091?ref=25 Autologous fibroblast therapy (Isolagen, Isolagen, Inc.) has been used to achieve functional and cosmetic improvements in patients with acute and chronic burn injuries involving the face, neck, hands, and chest. The treatment was safe and well-tolerated and associated with high patient satisfaction. 2008-07-01T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/282008/528091null XML http://www.modernmedicine.com/modernmedicine/Cosmetic+Dermatology/Making-the-grade-Lip-volume-scale-shows-reliabilit/ArticleStandard/Article/detail/528115?ref=25 The first validated scale for grading lip volume has proven its accuracy and robustness in a variety of tests, according to one of the scale's developers. 2008-07-01T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/282008/528115null XML http://www.modernmedicine.com/modernmedicine/Other/Misnomer-Tropical-Dermatology/ArticleStandard/Article/detail/528090?ref=25 Dermatologists must look outside their regional communities for the source of unique symptoms. A history of tropical travel isn't always a precursor to tropical disease. 2008-07-01T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/282008/528090null XML http://www.modernmedicine.com/modernmedicine/Psoriasis/Promising-outlook-Study-shows-efalizumab-provides-/ArticleStandard/Article/detail/528095?ref=25 The results of a three-year study with efalizumab show that patients with moderate-to-severe psoriasis are able to maintain high PASI scores, reflecting long-term hope for disease-free intervals. 2008-07-01T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/282008/528095null XML http://www.modernmedicine.com/modernmedicine/Rosacea/Rosacea-treatments-Delayed-release-doxycycline-40-/ArticleStandard/Article/detail/528099?ref=25 Study shows comparable efficacy and onset of therapeutic effect with doxycycline 40 mg (delayed release) once daily or doxycycline 100 mg once daily for treatment of rosacea, with some differences in adverse effects. 2008-07-01T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/282008/528099null XML http://www.modernmedicine.com/modernmedicine/Skin+Cancer/The-government-and-dermatologic-surgery-Reimbursem/ArticleStandard/Article/detail/528128?ref=25 Government reimbursements for dermatologic procedures are shrinking, while the number of cases of skin cancer continue to rise. 2008-07-01T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/282008/528128null XML http://dermatologytimes.modernmedicine.com/dermatologytimes/Modern+Medicine+News/Volunteers-tee-off-on-skin-cancer-with-free-exams-/ArticleStandard/Article/detail/526026?ref=25 Havre de Grace, Md. — Skin cancer screenings and sun safety outreach were offered at one of the major tournaments in the women’s professional golf tour, SunHerald.com reports. 2008-07-01T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/262008/526026null HTML http://www.modernmedicine.com/modernmedicine/Skin+Cancer/Basal-cell-carcinomas-Doctors-look-to-nonsurgical-/ArticleStandard/Article/detail/528119?ref=25 Dermatologists have been growing increasingly comfortable and confident with nonsurgical treatments for basal cell carcinomas, according to one expert. 2008-07-01T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/282008/528119null XML http://www.modernmedicine.com/modernmedicine/Office+Management/Opinions-Growing-medspa-industry-shrinking-economy/ArticleStandard/Article/detail/528082?ref=25 Over the past 10 to 15 years, there has been a boom in the phenomenon commonly known as "medspas" — an outgrowth of the purely Aesthetic day spa, combining herbal wraps and massages with medical or near-medical therapies, such as microdermabrasion and chemical peels, and progressing into lasers, fillers and Botox treatments. 2008-07-01T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/282008/528082null XML http://www.modernmedicine.com/modernmedicine/Letters+to+the+Editor/Letter-to-the-editor-Physician-offers-alternatives/ArticleStandard/Article/detail/528083?ref=25 Dr. Norman Levine (Commentary, May 2008) should be applauded for his bravery in publicly questioning the relative value of skin cancer screening events. 2008-07-01T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/282008/528083null XML http://www.modernmedicine.com/modernmedicine/Cosmetic+Dermatology/Autologous-fibroblast-therapy-Pivotal-trials-drawi/ArticleStandard/Article/detail/528110?ref=25 Two identical pivotal trials evaluating the safety and efficacy of autologous fibroblast therapy (Isolagen Technologies) compared with placebo are almost finished. Special attention was paid in protocol design so there would be consistency across the studies in cell harvesting and injection technique, as well as in outcomes assessments. The treatment protocol, which varies from previous studies, aims to optimize the treatment effect. 2008-07-01T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/282008/528110null XML http://www.modernmedicine.com/modernmedicine/Irritant/Hand-dermatitis-Patch-testing-could-play-predictiv/ArticleStandard/Article/detail/528101?ref=25 Patch-testing might be a helpful tool in determining individuals who may be at risk for developing irritant hand dermatitis, according to a recent study. 2008-07-01T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/282008/528101null XML http://www.modernmedicine.com/modernmedicine/Ethnic+Skin/Black-is-beautiful-Looking-at-skin-concerns-of-pat/ArticleStandard/Article/detail/528105?ref=25 When treating patients of color, dermatologists need to be aware of unique concerns and make an earlier diagnosis of serious problems, such as cancer, an expert says. 2008-07-01T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/282008/528105/66_flash.jpg XML http://www.modernmedicine.com/modernmedicine/Cosmetic+Dermatology/Antioxidant-anti-aging-cream-passes-multifaceted-e/ArticleStandard/Article/detail/528113?ref=25 A new, antioxidant-rich skin cream has demonstrated efficacy regarding a range of anti-aging parameters, researchers say. 2008-07-01T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/282008/528113null XML http://www.modernmedicine.com/modernmedicine/Skin+Cancer/Judgment-call-Difficult-Squamous-Cell-Carcinomas-r/ArticleStandard/Article/detail/528126?ref=25 Treating patients with multiple SCCs requires clearing dermal disease first, then addressing field in situ disease topically; physicians are frequently required to make judgment calls, an expert says. 2008-07-01T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/282008/528126null XML http://www.modernmedicine.com/modernmedicine/Skin+Cancer/Standing-watch-Sentinel-lymph-node-biopsy-demonstr/ArticleStandard/Article/detail/528120?ref=25 Emerging data indicate the sentinel lymph node biopsy may not only stage the regional lymph nodes of patients with melanoma and have prognostic value, but may be therapeutic as well. Data from the Multicenter Selective Lymphadenectomy Trial (MSLT-1), an investigation consisting of patients with clinically node-negative melanoma, demonstrated a survival advantage in a subset of patients who had a positive node. 2008-07-01T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/282008/528120null XML http://www.modernmedicine.com/modernmedicine/Skin+Cancer/Nonmelanoma-skin-cancers-Alarming-incidence-rates-/ArticleStandard/Article/detail/528121?ref=25 Incidence rates of nonmelanoma skin cancers may be higher than estimated. Ultraviolet light-induced skin cancer is an occupational disease, according to one expert. 2008-07-01T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/282008/528121null XML http://www.modernmedicine.com/modernmedicine/Skin+Cancer/Detecting-melanoma-Digital-dermoscopy-total-body-p/ArticleStandard/Article/detail/528123?ref=25 Diagnostics techniques such as dermoscopy, total body photography and digital dermoscopy can assist the dermatologist in diagnosing troublesome nevi and catching early melanomas more frequently. 2008-07-01T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/282008/528123null XML http://www.modernmedicine.com/modernmedicine/Skin+Cancer/And-dermoscopy-for-all-Three-point-checklist-helps/ArticleStandard/Article/detail/528124?ref=25 A three-point checklist applied in dermoscopy could significantly assist non-experts of dermoscopy to accurately diagnose suspicious skin lesions, according to a recent study. 2008-07-01T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/282008/528124null XML http://www.modernmedicine.com/modernmedicine/Skin+Cancer/Actinic-keratoses-What-are-the-risks-if-left-untre/ArticleStandard/Article/detail/528125?ref=25 Many physicians believe that if left untreated, actinic keratoses will become a grave danger to the patient. According to a French dermatologist, however, actinic keratosis usually poses no threat to the life of the patient, and the immediate treatment of these lesions is not mandatory, provided that the AKs that evolve into more advanced tumors are detected and treated, and that patients are not immunosuppressed. 2008-07-01T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/282008/528125null XML http://www.modernmedicine.com/modernmedicine/Finance/Going-offshore-Is-international-asset-planning-rig/ArticleStandard/Article/detail/528134?ref=25 Over the last decade, an increasing number of doctors have looked at international approaches to their wealth planning. There are numerous pitfalls for using international planning that can catch naïve doctors. Learn what to do — and what to avoid — in international planning, and about specific tools top attorneys use in their international planning. 2008-07-01T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/282008/528134null XML http://www.modernmedicine.com/modernmedicine/Physician%27s+Profile/Physicians-profile-Chicago-dermatologist-focuses-c/ArticleStandard/Article/detail/528135?ref=25 Mario E. LaCouture, M.D., discovered during his residency that the role of dermatology in cancer patients' lives was much greater than just treating skin cancers. He would watch as breast, lung, colon and other cancer patients would complain about the damage that anticancer treatments — especially the new biologics — were doing to their skin. Patients in phase 1 and 2 clinical trials, who had exhausted their treatment options, were having to forgo life-prolonging treatment because of life-altering cutaneous effects, including itching so severe that they could not function or sleep. 2008-07-01T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/282008/528135/138_flash.jpg XML http://dermatologytimes.modernmedicine.com/dermatologytimes/E-newsletter/NRS-survey-suggests-links-between-rosacea-and-gene/ArticleStandard/Article/detail/526025?ref=25 Barrington, Ill. — Results of a recently released survey indicate that rosacea may be genetic, the National Rosacea Society (NRS) reports. 2008-07-01T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/262008/526025null HTML http://dermatologytimes.modernmedicine.com/dermatologytimes/Modern+Medicine+News/Study-recommends-daily-counts-to-assess-degree-of-/ArticleStandard/Article/detail/526021?ref=25 Houston — A new study shows that people worried about hair loss can count on counting as a way to find out if their concerns are justified, HealthDay News reports. 2008-07-01T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/262008/526021null HTML http://www.modernmedicine.com/modernmedicine/Psoriasis/New-hope-Biologics-target-IL-12-and--23-in-treatin/ArticleStandard/Article/detail/528097?ref=25 Two biologic agents under investigation show promise in the treatment of psoriasis by targeting IL-12 and -23, says an expert. 2008-07-01T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/282008/528097null XML http://www.modernmedicine.com/modernmedicine/Cosmetic+Dermatology/Perceived-age-Eyes-skin-tone-give-away-years/ArticleStandard/Article/detail/528108?ref=25 A study showing that the periocular area and skin color uniformity are key drivers of perceived age suggests that aesthetic physicians and skincare companies should target these attributes, authors say. 2008-07-01T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/282008/528108null XML http://www.modernmedicine.com/modernmedicine/Cosmetic+Dermatology/Laser-eye-safety-How-to-keep-you-your-staff-and-yo/ArticleStandard/Article/detail/528111?ref=25 With the continued introduction of laser devices with unique delivery systems and wavelengths, the issue of eye safety is becoming increasingly complicated. Consistent and competent eye safety procedures for operator, patient, observer and assistant are crucial to a safe and successful laser practice. Despite our increased knowledge of lasers and laser safety, eye injuries in the workplace are still a common problem, with many injuries going undetected well after the incident. 2008-07-01T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/282008/528111null XML http://www.modernmedicine.com/modernmedicine/Skin+Cancer/Mohs-goes-South-Micrographic-surgery-gaining-footh/ArticleStandard/Article/detail/528130?ref=25 The Mohs surgeon who introduced the technique in Brazil shares practical tips for successful Mohs surgery. 2008-07-01T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/282008/528130null XML http://www.modernmedicine.com/modernmedicine/Office+Management/Worth-a-thousand-words-Pictures-can-speak-volumes-/ArticleStandard/Article/detail/528131?ref=25 Clinical photography in dermatology can be an invaluable tool, if used properly. Following some basic guidelines can take the guesswork out, lend credibility and present a much more accurate picture. 2008-07-01T04:00:00Z http://dermatologytimes.modernmedicine.com/dermatologytimes/data/articlestandard/dermatologytimes/282008/528131null XML